Clinical Trial Update: Association Between Drug-related Cutaneous Adverse Events and Progression Free Survival in Patients Treated with Enfortumab Vedotin

View source ↗

Summary

This clinical trial update evaluates whether enfortumab vedotin–associated cutaneous adverse events correlate with progression-free survival in patients treated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Padcev (enfortumab vedotin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cutaneous Adverse | Status: COMPLETED